BDX Becton, Dickinson and Company
$183.82
Becton, Dickinson and Company (BDX) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is $4.06 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.5% since its last earnings release on August 6, 2026.
Becton, Dickinson Beat Consensus Estimates, Narrows Guidance Above Estimates
Thursday, August 6, 2026 · 6:30 AM ET
Earnings Date
4th Quarter, Sep 2026
Nov 9
Monday · 6:30 AM ET
Earnings Whisper
-
vs $4.06
Rev est $5.12B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$183.47
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Becton, Dickinson and Company
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.
Sector
Healthcare
Industry
Medical Instruments/Supply
Held By 10 ETFs, by dollar flow
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- BMED iShares Health Innovation Active ETF
- BMED iShares Health Innovation Active ETF
- IHI iShares U.S. Medical Devices ETF
- IHI iShares U.S. Medical Devices ETF
Charts powered in part by Lightweight Charts™ by TradingView.